Outpatients who were administered curcumin (CUR) and quercetin (QUE) after testing positive for early-stage SARS-CoV-2 were found to clear the virus at a significantly faster rate, compared to those receiving standard of care (SOC) alone.
Scientists have developed a method to bind quercetin derivatives to pectin chains to enhance bioavailability and antioxidant activity for improved disease prevention.
Quercetin supplements combined with low-intensity resistance exercise may improve measures of muscle stiffness in older people and may benefit those at risk of sarcopenia.
Tradichem Industrial Services (TIS) has signed a global licensing agreement with nutraceutical supplier Cellmark Ingredients for distribution of its granular quercetin and granular CoQ10 antioxidants.
Indena is using its proprietary phytosome delivery system, to study a more bioavailable formulation of quercetin, with preliminary clinical evidences in allergy control.
